Skip to main content
SpringerLink
Log in

Reduction of pulmonary edema after SAH with a pulmonary artery catheter-guided hemodynamic management protocol

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Introduction: The frequency of pulmonary edema, which occurs with high frequency following subarachnoid hemorrhage (SAH), can be worsened by hypervolemic, hypertensive, hemodilution therapy for vasospasm. This study compares the complication rates for patients with SAH before and after institution of a pulmonary artery catheter-guided hemodynamic management protocol.

Methods: Complication and outcome data were prospectively collected on 453 patients with spontaneous SAH. The patients were divided into groups treated from July 1998 through January 2000 (n=174) and from February 2002 through June 2002 (n=279). In group I, treatment consisted of hypervolemia (central venous pressures: >8 mmHg) and hypertension (mean arterial pressure: 110–130 mmHg). In group II, normovolemia was the goal, defined using a pulmonary artery catheter (wedge pressure: 10–14 mmHg). Cardiac output was enhanced (index: >4.5 L/minute/m2), and blood pressure elevations were moderated (mean pressure: >100 mmHg).

Results: The average age, comorbidity, hemorrhage severity, and incidence of vasospasm were almost identical between the two groups. Statistically significant reductions were noted in patients in group II for two types of complications as well as for mortality. The rate of pulmonary edema (from 14 to 6%) and the rate of sepsis (from 14 to 6%) were both decreased (p≤0.03). Mortality decreased from 34 to 29% (p=0.04). Other complications, such as myocardial infarction, were not affected.

Conclusions: These data show that a significant reduction in the frequency of pulmonary edema after SAH can be attained using a pulmonary artery catheter-guided hemodynamic management protocol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Awad IA, Carte LP, Spetzler RF, Medina M, Williams FW Jr. Clinical vasospasm after subarachnoid hemorrhage-response to hypervolemic hemodilution and arterial hypertension. Stroke 1987;18:365–372.

    PubMed  CAS  Google Scholar 

  2. Giannotta SL, McGillicuddy JE, Kindt GW. Diagnosis and treatment of postoperative cerebral vasospasm. Surg Neurol 1977;8:286–290.

    PubMed  CAS  Google Scholar 

  3. Kassell NF, Peerless SJ, Cuward QJ. Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery 1978;3:364–368.

    Article  Google Scholar 

  4. Kassell NF, Peerless SJ, Cuward QJ, Beck DW, Drake CG, Adams HP. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982;11:337–343.

    Article  PubMed  CAS  Google Scholar 

  5. Kassell NF, Sasaki T, Colohan ART. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985;16:562–572.

    PubMed  CAS  Google Scholar 

  6. Kosnick EJ, Hunt WE. Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg 1976;45:148–154.

    Article  Google Scholar 

  7. Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 2000;31:383–391.

    PubMed  CAS  Google Scholar 

  8. Levy ML, Giannotta SL. Cardiac performance indices during hypervolemic therapy for cerebral vasospasm. J Neurosurg 1991;75:27–31.

    PubMed  CAS  Google Scholar 

  9. Mayberg MR. Cerebral vasospasm. Neurosurgery Clinics of North America 1998;9:615–627.

    PubMed  CAS  Google Scholar 

  10. Miller JA, Dacey RG, Diringer MN. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 1995;26:2260–2266.

    PubMed  CAS  Google Scholar 

  11. Origitano TC, Wascher TM, Reichman OH, Anderson DE. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (“Triple-H” therapy) after subarachnoid hemorrhage. Neurosurgery 1990;27:729–740.

    Article  PubMed  CAS  Google Scholar 

  12. Otsubo H, Takemae T, Inoue T, Kobayashi SH, Sugita K. Normovolemic induced hypertension therapy for cerebral vasospasm after subarachnoid hemorrhage. Acta Neurochir (Wien) 1990;103:18–26.

    Article  CAS  Google Scholar 

  13. Rosenwasser RH, Delgado TE, Buchheit WA. Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage; a preliminary report. Neurosurgery 1983;12:658–661.

    Article  PubMed  CAS  Google Scholar 

  14. Solomon RA, Fink ME, Lennihan L. Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery 1988;23:699–704.

    Article  PubMed  CAS  Google Scholar 

  15. Vander Ark GD, Pomerants M. Reversal of ischemic neurological signs by increasing cardiac output. Surg neurol 1973;1:257,258.

    Google Scholar 

  16. Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 2003;98:978–984.

    PubMed  Google Scholar 

  17. Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurismal subarachnoid hemorrhage; a clinical prospective, randomized, controlled study. Neurosurgery 2001;49(3):593–606.

    Article  PubMed  CAS  Google Scholar 

  18. Oropello JM, Weiner L, Benjamin E. Hypertensive, hypervolemic, hemodilutional therapy for aneurysmal subarachnoid hemorrhage-is it efficacious? No. Critical Care Clinics 1996;12(3):710–731.

    Google Scholar 

  19. Findlay JM, Deagle GM. Causes of morbidity and mortality following intracranial aneurysm rupture. Can J Neurol Sci 1998;25:209–215.

    PubMed  CAS  Google Scholar 

  20. Friedman JA, Pichelmann MA, Pipgras DG, et al. Pulmonary Complications of aneurysmal subarachnoid hemorrhage. Neurosurgery 2003;52:1025–1032.

    Article  PubMed  Google Scholar 

  21. Gruber A, Reinprecht A, Illievich UM, et al. Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med 1999;27(3):505–514.

    Article  PubMed  CAS  Google Scholar 

  22. Haley EC Jr, Kassell NF, Torner JC. The international cooperative study on the timing of aneurysm surgery; the North American experience. Stroke 1992;23(2):205–214.

    PubMed  Google Scholar 

  23. Vermeij FJ, Hasan D, Bijvoet HWC, Avezaat CJJ. Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage. Stroke 1998;29:924–930.

    PubMed  CAS  Google Scholar 

  24. Weir B, Grace M, Hansen J, Rothberg C. Time course of vasospasm in man. J Neurosurg 1978;48:173–178.

    PubMed  CAS  Google Scholar 

  25. Medlock MD, Dulebohn SC, Elwood PW. Prophylactic hypervolemia without calcium channel blockers in early aneurysm surgery. Neurosurgery 1992;30:12–16.

    Article  PubMed  CAS  Google Scholar 

  26. Solenski NJ, Haley EC, Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Crit Care Med 1995;23(6):1007–1012.

    Article  PubMed  CAS  Google Scholar 

  27. Kim DH, Joseph M, Ziadi S, et al. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: s study using xenon-CT measurements of cerebral blood flow. Neurosurgery 2003;53:1–9.

    Google Scholar 

  28. Pittman JA, Ping JS, Mark JB. Arterial and central venous pressure monitoring. Int Anesthisiol Clin 2004;42:13–30.

    Article  Google Scholar 

  29. Tkachenko RL, Evlakhov VI, Poyasov IZ. Independence of changes in right atrial pressure and central venous pressure. Bull Exp Biol Med 2002;134:318–320.

    Article  PubMed  CAS  Google Scholar 

  30. Levy ML, Rabb CH, Zelman V, Giannotta SL. Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg 1993;79:494–499.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School, USA

    Dong H. Kim, Charles L. Haney & Grace Van Ginhoven

Authors
  1. Dong H. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles L. Haney
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Grace Van Ginhoven
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dong H. Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, D.H., Haney, C.L. & Van Ginhoven, G. Reduction of pulmonary edema after SAH with a pulmonary artery catheter-guided hemodynamic management protocol. Neurocrit Care 3, 11–15 (2005). https://doi.org/10.1385/NCC:3:1:011

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/NCC:3:1:011

Key Words

Search

Navigation